Risk factors in patients with venous thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 239s Year: 2002
Venous thromboembolic disease and bronchial cancer Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012
Treatment and prevention of cancer-associated venous thromboembolism Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management Year: 2021
Venous thromboembolism in lung cancer with clinical analysis of 89 cases Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012
Venous thromboembolism and pulmonary cancer: A ten years series Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010
Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
Persistent lung perfusion defect is a risk factor for recurrent venous thromboembolism after pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012
Factors associated with mortality and survival in venous thromboembolism and hidden or concurrent cancer Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015
Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis? Source: Eur Respir J 2016; 47: 369-373 Year: 2016
Clinical implications of incidental venous thromboembolism in cancer patients Source: Eur Respir J, 55 (2) 1901697; 10.1183/13993003.01697-2019 Year: 2020
Asthma and risk of pulmonary thromboembolism Source: Eur Respir J 2014; 43: 1534-1535 Year: 2014
Silent venous thromboembolism (VTE) in patients undergoing thoracic surgery in the course of lung cancer. Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
The incidence of serious venous thromboembolic events in 1157 lung cancer patients Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology Year: 2008
Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial Source: Eur Respir J, 51 (1) 1701202; 10.1183/13993003.01202-2017 Year: 2018
Analysis of risk factors in pulmonary thromboembolism Source: Eur Respir J 2006; 28: Suppl. 50, 45s Year: 2006
Clinical presentation and outcome of venous thromboembolism in COPD Source: Eur Respir J 2012; 39: 862-868 Year: 2012
COPD and risk of venous thromboembolism and mortality in a general population Source: Eur Respir J 2016; 47: 473-481 Year: 2016
Risk assessment of venous thromboembolism in lung cancer – Utility of Khorana model Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Long-term low molecular weight heparin treatment in cancer associated venous thromboembolism patients Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015
Incidental venous thromboembolism, detected by chance, but still venous thromboembolism Source: Eur Respir J, 55 (2) 2000028; 10.1183/13993003.00028-2020 Year: 2020